Martina Sester

Martina Sester's AcademicInfluence.com Rankings

Martina Sester

Biology

#14328

World Rank

#18049

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Martina Sester Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Martina Sester is a biologist, Professor of Transplantation and Infection Immunology and Head of Department of the Institute of Infection Medicine at Saarland University Hospital as well as former Vice President for Research and Technology Transfer at Saarland University.

(See a Problem?)

Martina Sester's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement (2009) (577)
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement (2010) (463)
Interferon-&ggr; release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis (2010) (416)
LEVELS OF VIRUS-SPECIFIC CD4 T CELLS CORRELATE WITH CYTOMEGALOVIRUS CONTROL AND PREDICT VIRUS-INDUCED DISEASE AFTER RENAL TRANSPLANTATION1 (2001) (241)
Molecular aspects of T- and B-cell function in uremia. (2001) (241)
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination (2021) (232)
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement (2012) (207)
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. (2014) (196)
Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention (1996) (176)
T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. (2000) (166)
PD‐1 Expression and IL‐2 Loss of Cytomegalovirus‐ Specific T Cells Correlates with Viremia and Reversible Functional Anergy (2008) (163)
Impaired cellular immune function in patients with end-stage renal failure. (1999) (157)
Differences in CMV‐Specific T‐Cell Levels and Long‐Term Susceptibility to CMV Infection after Kidney, Heart and Lung Transplantation (2005) (157)
Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. (2002) (134)
Sustained High Frequencies of Specific CD4 T Cells Restricted to a Single Persistent Virus (2002) (132)
Whole-Blood Flow-Cytometric Analysis of Antigen-Specific CD4 T-Cell Cytokine Profiles Distinguishes Active Tuberculosis from Non-Active States (2011) (126)
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation (2019) (125)
Monocyte heterogeneity in human cardiovascular disease. (2012) (123)
Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection. (2002) (117)
Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. (2004) (116)
Diagnosis and Management of Tuberculosis in Transplant Donors: A Donor‐Derived Infections Consensus Conference Report † (2012) (115)
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients (2008) (112)
Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. (2001) (110)
Evaluation of Use of Epstein-Barr Viral Load in Patients after Allogeneic Stem Cell Transplantation To Diagnose and Monitor Posttransplant Lymphoproliferative Disease (2002) (108)
Adenovirus E3/19K Promotes Evasion of NK Cell Recognition by Intracellular Sequestration of the NKG2D Ligands Major Histocompatibility Complex Class I Chain-Related Proteins A and B (2008) (102)
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients (2021) (96)
High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19 (2020) (87)
Levels of CMV Specific CD4 T Cells Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation (2008) (85)
Interferon-γ release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis (European Respiratory Journal (2011) 37, (100-111)) (2012) (84)
Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. (2006) (79)
Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment. (2001) (77)
Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease. (2000) (74)
The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen. (2012) (74)
The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. (2001) (73)
Impact of COVID-19 in solid organ transplant recipients (2020) (72)
Numerical modelling of label-structured cell population growth using CFSE distribution data (2007) (72)
BK Polyomavirus‐Specific Cellular Immune Responses Are Age‐Dependent and Strongly Correlate With Phases of Virus Replication (2014) (69)
The “ABC” of Virus‐Specific T Cell Immunity in Solid Organ Transplantation (2016) (69)
Is the cytomegalovirus serologic status always accurate? A comparative analysis of humoral and cellular immunity1 (2003) (66)
Age-related decrease in adenovirus-specific T cell responses. (2002) (65)
Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients. (2003) (65)
Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction. (2000) (64)
Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy. (2006) (58)
Diagnosis and treatment of latent infection with Mycobacterium tuberculosis (2013) (55)
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-alpha blocking drugs using a novel flow-cytometric interferon-gamma release assay. (2007) (53)
The fraction of perforin-expressing HIV-specific CD8 T cells is a marker for disease progression in HIV infection (2002) (52)
Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis (vol 37, pg 100, 2011) (2012) (52)
Uremia-associated immune defect: the IL-10-CRP axis. (2003) (51)
Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection. (2015) (49)
Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection (2010) (48)
Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer. (2006) (47)
miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signaling (2019) (45)
Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA (2007) (45)
Vaccination of the solid organ transplant recipient. (2008) (45)
Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor-based drug regimens. (2009) (44)
T-cell Numbers and Antigen-specific T-cell Function Follow Different Circadian Rhythms (2012) (44)
Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs (2009) (44)
The Amyloid Precursor-like Protein 2 Associates with the Major Histocompatibility Complex Class I Molecule Kd * (2000) (40)
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings (2020) (39)
A unique secreted adenovirus E3 protein binds to the leukocyte common antigen CD45 and modulates leukocyte functions (2013) (39)
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab (2020) (38)
Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection (2000) (36)
CD4+ T‐cell immunity after pandemic influenza vaccination cross‐reacts with seasonal antigens and functionally differs from active influenza infection (2012) (35)
Blockade of programmed death receptor‐1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus‐specific T cells (2013) (34)
Quantitative, Phenotypical, and Functional Characterization of Cellular Immunity in Children and Adolescents With Down Syndrome (2017) (34)
Immunogenicity and reactogenicity of a heterologous COVID-19 prime-boost vaccination compared with homologous vaccine regimens (2021) (31)
Different Munc13 Isoforms Function as Priming Factors in Lytic Granule Release from Murine Cytotoxic T Lymphocytes (2013) (30)
Elite athletes on regular training show more pronounced induction of vaccine-specific T-cells and antibodies after tetravalent influenza vaccination than controls (2020) (29)
PD‐1 Analysis on CD28−CD27− CD4 T Cells Allows Stimulation‐Independent Assessment of CMV Viremic Episodes in Transplant Recipients (2013) (27)
Conserved Amino Acids within the Adenovirus 2 E3/19K Protein Differentially Affect Downregulation of MHC Class I and MICA/B Proteins (2009) (26)
miR-34a as hub of T cell regulation networks (2019) (26)
Allergic airway inflammation induces the migration of dendritic cells into airway sensory ganglia (2014) (26)
Selective sequestration of cytokine-producing monocytes during hemodialysis treatment. (2001) (25)
Antigen-Specific CD4 T Cells Are Induced after Intravesical BCG-Instillation Therapy in Patients with Bladder Cancer and Show Similar Cytokine Profiles as in Active Tuberculosis (2013) (24)
Detection of antigen-specific T cells based on intracellular cytokine staining using flow-cytometry. (2013) (23)
A shift in the Th1/Th2 ratio accompanies the clinical remission of systemic lupus erythematosus in patients with end‐stage renal disease (2002) (23)
Cytomegalovirus‐specific T cells are detectable in early childhood and allow assignment of the infection status in children with passive maternal antibodies (2013) (23)
The Transmembrane Domain of the Adenovirus E3/19K Protein Acts as an Endoplasmic Reticulum Retention Signal and Contributes to Intracellular Sequestration of Major Histocompatibility Complex Class I Molecules (2013) (22)
TBNET - Collaborative research on tuberculosis in Europe. (2012) (21)
Comparative Analysis of Assays for Detection of Cell‐Mediated Immunity Toward Cytomegalovirus and M. tuberculosis in Samples From Deceased Organ Donors (2014) (21)
Cytomegalovirus-specific T-cell immunity to assign the infection status in individuals with passive immunity: a proof of principle. (2012) (21)
Increase of Mast Cell-Nerve Association and Neuropeptide Receptor Expression on Mast Cells in Perennial Allergic Rhinitis (2016) (20)
Serial influenza-vaccination reveals impaired maintenance of specific T-cell memory in patients with end-stage renal failure. (2013) (19)
Monitoring of CMV-specific T-cell levels after organ transplantation / Monitoring CMV-spezifischer T-Zellen nach Organtransplantation (2008) (18)
Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens (2022) (18)
Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells (2016) (18)
A shift in the Th(1)/Th(2) ratio accompanies the clinical remission of systemic lupus erythematosus in patients with end-stage renal disease. (2002) (18)
Mutated Ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: a pilot trial. (2012) (17)
Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence (2017) (17)
Numbers needed to treat to prevent tuberculosis (2015) (17)
Quantity, quality, and functionality of peripheral blood cells derived from residual blood of different apheresis kits (2018) (17)
Antigen-specific T cell responses: determination of their frequencies, homing properties, and effector functions in human whole blood. (2006) (16)
Superior Sensitivity of Ex Vivo IFN‐γ Release Assays as Compared to Skin Testing in Immunocompromised Patients (2015) (15)
Maintenance of HIV-specific central and effector memory CD4 and CD8 T cells requires antigen persistence. (2007) (15)
European survey on the management of tuberculosis in solid‐organ transplant recipients and candidates (2013) (14)
Dynamics of CD81 expression on lymphocyte subsets during interferon‐α‐based antiviral treatment of patients with chronic hepatitis C (2006) (14)
Differentiation of Monocyte Derived Dendritic Cells in End Stage Renal Disease is Skewed Towards Accelerated Maturation. (2015) (14)
Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients (2015) (13)
Successful outcome of kidney transplantation from a HBV-DNA positive donor into recipients with cleared HBV-infection using a pre-emptive therapy approach. (2010) (12)
Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophages (2020) (12)
Development of an improved ESAT-6 and CFP-10 peptide-based cytokine flow cytometric assay for bovine tuberculosis. (2015) (12)
Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies. (2008) (12)
CTLA‐4‐expression on VZV‐specific T cells in CSF and blood is specifically increased in patients with VZV related central nervous system infections (2018) (11)
Quantitative and time-resolved miRNA pattern of early human T cell activation (2020) (11)
Estimation of Human Herpesvirus 8 Prevalence in High-Risk Patients by Analysis of Humoral and Cellular Immunity (2007) (11)
High levels of SARS-CoV-2 specific T-cells with restricted functionality in patients with severe course of COVID-19 (2020) (11)
Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient (2016) (10)
Viral Load and Risk of Tuberculosis in HIV Infection. (2016) (10)
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-blocking drugs using a novel flow-cytometric interferon-release assay (2008) (10)
BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation (2020) (10)
Timing of Vaccination after Training: Immune Response and Side Effects in Athletes (2020) (10)
Rapid Identification of Preformed Alloreactive T Cells for Use in a Clinical Setting (2004) (10)
Evaluation of antigen specific interleukin-1β as a biomarker to detect cattle infected with Mycobacterium bovis. (2017) (9)
Management of tuberculosis in HIV infection: where T-cells matter (2010) (9)
Tuberculosis in Transplantation: Diagnosis, Prevention, and Treatment (2012) (9)
High-dose intranasal application of titanium dioxide nanoparticles induces the systemic uptakes and allergic airway inflammation in asthmatic mice (2020) (9)
VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs (2018) (8)
Cellular immunity predominates over humoral immunity after the first dose of COVID-19 vaccines in solid organ transplant recipients (2021) (8)
Assigning Cytomegalovirus Status in Children Awaiting Organ Transplant: Viral Shedding, CMV-Specific T Cells, and CD27−CD28−CD4+ T Cells (2018) (8)
Massive monoclonal expansion of CD4 T-cells specific for a Mycobacterium tuberculosis ESAT-6 peptide (2012) (7)
What defines latent infection with Mycobacterium tuberculosis in patients with autoimmune diseases? (2015) (7)
Class I Chain-Related Proteins A and B . NKG 2 D Ligands Major Histocompatibility Complex Recognition by Intracellular Sequestration of the Adenovirus E 3 / 19 K Promotes Evasion of NK Cell 2008 (2008) (7)
Immunological biocompatibility characterization of a vitamin E-bonded membrane. (1999) (7)
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens (2022) (7)
The future of SARS-CoV-2 vaccines in transplant recipients: To be determined (2021) (6)
Decreased Migration of Dendritic Cells into the Jugular-Nodose Ganglia by the CXCL12 Neutraligand Chalcone 4 in Ovalbumin-Sensitized Asthmatic Mice (2018) (6)
Screening for latent infection with Mycobacterium tuberculosis: a plea for targeted testing in low endemic regions (2012) (6)
Effect of everolimus‐based drug regimens on CMV‐specific T‐cell functionality after renal transplantation: 12‐month ATHENA subcohort‐study results (2020) (6)
TB or not TB: The role of immunodiagnosis (2012) (6)
Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis (2022) (6)
Head-to-head analysis of IGRAs and skin-testing in immunocompromised patients: Interim analysis of a multicenter TBNET study (2011) (6)
Tuberculosis Network European Trialsgroup (TBNET) 2012 (2013) (5)
Tuberculosis in the immunocompromised host (2013) (5)
Steroid Treatment Reduces Allergic Airway Inflammation and Does Not Alter the Increased Numbers of Dendritic Cells and Calcitonin Gene-Related Peptide-Expressing Neurons in Airway Sensory Ganglia (2015) (5)
Robust method for isolation of tumor infiltrating lymphocytes with a high vital cell yield from small samples of renal cell carcinomas by a new collagenase-free mechanical procedure. (2018) (4)
CMV-specific T-cells and CD27-CD28-CD4+ T-cells for assignment of cytomegalovirus (CMV) status in adults awaiting organ transplant. (2019) (4)
Interferon-&ggr; release assays for diagnosis of active pleural tuberculosis: a developing world perspective (2011) (4)
TB in the immunocompromised host (2012) (4)
Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis (2022) (4)
Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection. (2016) (4)
Donor‐specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation (2017) (4)
Pathogen prevalence may determine maintenance of antigen-specific T-cell responses in HIV-infected individuals (2012) (3)
Evaluation of Use of Epstein-Barr Viral Load in Patients after Allogeneic Stem Cell Transplantation To Diagnose and Monitor Posttransplant Lymphoproliferative Disease (2002) (3)
Rapid reconstitution of CMV‐specific T‐cells after stem‐cell transplantation (2018) (3)
Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination (2021) (3)
Cytomegalievirus bei Nierentransplantation – Diagnose, Prävention und Management (2015) (3)
Novel human sex-typing strategies based on the autism candidate gene NLGN4X and its male-specific gametologue NLGN4Y (2019) (3)
Boosting immunity after CoronaVac (2022) (2)
[The impact of immunosuppression and chronic kidney disease on immunogenicity of COVID-19 vaccines]. (2021) (2)
Letter to the Editor regarding Dounousi E et al. Intact FGF23 and α‐Klotho during acute inflammation/sepsis in CKD patients (2017) (2)
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021 (2022) (2)
Research priorities for HIV/M. tuberculosis co-infection (2011) (2)
Assay for improved detection of antigen‐specific immune cells from extrasanguinous fluids (2018) (2)
Alloreactive T Cells to Identify Risk HLA Alleles for Retransplantation After Acute Accelerated Steroid-Resistant Rejection. (2015) (2)
Ways to boost cellular immunity in solid organ transplant recipients – The case of letermovir (2022) (1)
Diversity of antibody responses after influenza infection or vaccination—Needed or nice to have? (2021) (1)
Poster Session (2011) (1)
MP72-01 WHOLE-BLOOD PERFUSION IN A PORCINE MODEL FOR NORMOTHERMIC EXTRACORPORAL KIDNEY PERFUSION (NEKIP) – A MODEL FOR IMMUNOLOGICAL STUDIES (2014) (1)
MHC/Peptide-Specific Interaction of the Humoral Immune System: A New Category of Antibodies (2015) (1)
What de fi nes latent infection with Mycobacterium tuberculosis in patients with autoimmune diseases ? (2015) (1)
BK Virus-Specific Immune Responses Are Age-Dependent and Strongly Correlate with Phases of Virus Replication: 1898 (2012) (1)
T-cell Numbers and Antigen-specific T-cell Function Follow Different Circadian Rhythms (2012) (1)
Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis. (2015) (1)
A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis (2020) (1)
Testing for LTBI: more of the same or a step forward? (2018) (1)
Bridging the gap_Estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel (2022) (1)
The transmembrane domain of the adenovirus E3/19K protein acts as an ER retention signal and contributes to intracellular sequestration of MHC class I molecules (2013) (1)
miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signaling (2019) (1)
Corrigendum to "Development of an improved ESAT-6 and CFP-10 peptide-based cytokine flow cytometric assay for bovine tuberculosis" [Comp. Immunol. Microbiol. Infect. Dis. 42 (2015) 1-7]. (2016) (1)
Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis (2023) (1)
PREVALENCE OF CYTOMEGALO- AND ADENOVIRUS SPECIFIC T-CELLS IN CORRELATION TO VIRUS DNA AND -SEROLOGY BEFORE PEDIATRIC RENAL TRANSPLANTATION: 575 (2008) (0)
Transplantation / Basic research (2011) (0)
World-Wide Challenges and Perspectives for Handling HIV/Mycobacterium tuberculosis Co-Infections (2011) (0)
Evaluation of IFNγ release assays for detection of cellular immunity towards M. tuberculosis and CMV in samples from deceased donors (2013) (0)
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings (2020) (0)
Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients (2015) (0)
Method for detecting antigen-specific immune cells in extrasanguine fluids (2015) (0)
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation (2019) (0)
Combined Analysis of Multiple Inhibitory T Cell Receptors on Cytomegalovirus Specific CD4 T Cells Allows Identification of Patients at Risk for Viral Reactivation after Transplantation: 2262 (2012) (0)
Transient infection with SARS-CoV-2 without induction of systemic immunity (2021) (0)
(723) - CMV-Specific T-Cell Immunity and CMV NAAT in Assignment of CMV Status in Pediatric SOT Candidates (2017) (0)
703 Flow cytometry based immunoassay to monitor the BCG-therapy of the non muscle invasive bladder cancer (2013) (0)
Novel human sex-typing strategies based on the autism candidate gene NLGN4X and its male-specific gametologue NLGN4Y (2019) (0)
Contents Vol. 23, 2016 (2017) (0)
Transient Positive SARS-CoV-2 PCR without Induction of Systemic Immune Responses (2023) (0)
Preformed Cellular Alloreactivity Is Associated With Human Leukocyte Antigen Mismatches.: Abstract# A14 (2014) (0)
Phenotype and Functionality of Varicella Zoster Virus-Specific Cellular Immunity as Correlate of Protection in Immunocompetent and Immunocompromised Individuals: 1483 (2012) (0)
Comparative Analysis of Assays for Detection of Cellular Immunity Towards CMV and M. Tuberculosis in Samples from Deceased Donors: 1077 (2012) (0)
Cytomegalovirus monitoring using two different commercial PCR assays (2006) (0)
COVID-19 in a pediatric cancer patient with T-lymphoblastic lymphoma: Response to convalescence plasma and subsequent induction of SARS-CoV-2 specific humoral and cellular immunity despite strong B-cell lymphopenia (2021) (0)
Epstein-Barr virus in plasma and whole blood (2006) (0)
Head-to-head analysis of immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens (2021) (0)
AB0031 Restricted T-Cell Frequencies and Function in Patients with Rheumatoid Arthritis Revealed by a Whole Blood Stimulation Assay Using Polyclonal and Varicella Zoster Virus-Specific Stimuli (2015) (0)
CXCL12 neutraligand chalcone 4 inhibits migration of intraganglionic DC in an OVA-sensitized mouse model for allergic airway inflammation (2018) (0)
FOLLOW-UP OF CYTOMEGALO- UND ADENOVIRUS- SPECIFIC T CELLS DURING THE FIRST YEAR AFTER PEDIATRIC KIDNEY TRANSPLANTATION: 1886 (2008) (0)
of Quality-Controlled 16S rRNA Gene Sequence Databases: Identifying Nontuberculous Mycobacterium Species (2001) (0)
Affect Downregulation of MHC Class I and Adenovirus 2 E 3 / 19 K Protein Differentially Conserved Amino Acids within the Beatrice Menz (2009) (0)
Identification of amino acid residues within the E3/19K protein of adenovirus type 2 critically involved in HLA binding (1997) (0)
S87 Discovery and validation of a personalised risk predictor for incident tuberculosis in settings aiming towards pre-elimination (PERISKOPE-TB) (2021) (0)
Immunogenicity and reactogenicity of heterologous Ad26.COV.2 and BNT162b2 vaccination (2021) (0)
Interaction of the humoral immune system with peptides presented by class I major histocompatibility (MHC) complexes (42.4) (2012) (0)
Data on immunogenicity and reactogenicity to COVID-19 vaccination among patients receiving maintenance dialysis (2022) (0)
Unpacking the COVID-19 vaccine responses: Do we have what we need for a successful trip? (2021) (0)
Children with Down's Syndrome Show Quantitative, Phenotypical and Functional Differences of Effector T-Cells Compared to Immunocompetent Controls (2016) (0)
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings Authors (2020) (0)
Evaluation of QuantiFERON-CMV Assay for Detection of CMV-Specifi c Cellular Immunity in Immunocompromised Patients.: Abstract# A21 (2014) (0)
Cytokine profiling of specific T cells in patients after BCG-therapy allows distinction between patients with primary infection and prior contact (2013) (0)
The MHC Kd molecule interacts with the amyloid precursor like protein 2 (1997) (0)
IgG4 serum levels are not elevated in cases of Post-COVID syndrome (2023) (0)
Cellular and humoral immunity towards parental SARS-CoV-2 and variants of concern after two doses of the NVX-CoV2373-vaccine in comparison to homologous BNT162b and mRNA1273 regimens (2022) (0)
Supplementary Material for: Increase of Mast Cell-Nerve Association and Neuropeptide Receptor Expression on Mast Cells in Perennial Allergic Rhinitis (2016) (0)
Refined Assessment of the CMV Infection Status by Determination of CMV Specific T-Cell Immunity in Children with Passive Maternal Antibody Titers: 2535 (2012) (0)
SARS-CoV-2 specific cellular and humoral immunity after bivalent BA.4/5 COVID-19 vaccination in previously infected and non-infected individuals (2023) (0)
ANALYSIS OF AGREEMENT BETWEEN IGRAS AND TUBERCULIN SKIN-TESTING BY THE USE OF PPD AS THE SAME ANTIGEN: 3378 (2010) (0)
Posttransplant tuberculosis in Europe – a TBnet study (2019) (0)
This information is current as of Antibodies Humoral Immune System : A New Category MHC / Peptide-Specific Interaction of the Sester (2015) (0)
Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals (2014) (0)
457 DIFFERENTIAL EFFECTS OF IMMUNOSUPPRESSIVE DRUGS ON REGULATORY T-CELL FUNCTION (2010) (0)
Time-resolved RNA signatures of CD4+ T cells in Parkinson’s disease (2023) (0)
Pathophysiology and clinical studies in CKD 5D (2011) (0)
Erratum: Diagnosis and management of tuberculosis in transplant donors: A donor-derived infections consensus conference report (American Journal of Transplantation (2012) 12 (2288 -2300) DOI: 10.1111/j.1600-6143.2012.04205.x) (2013) (0)
A novel Rift Valley fever vaccine (2023) (0)
New method for improved detection of antigen-specific immune cells in liquids extrasanguinen (2014) (0)
Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity (2021) (0)
Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form (2023) (0)
Tuberculosis in immunocompromised patients (2019) (0)
Front & Back Matter (2012) (0)
Complex Class I Molecules Sequestration of Major Histocompatibility and Contributes to Intracellular Endoplasmic Reticulum Retention Signal Adenovirus E3/19K Protein Acts as an The Transmembrane Domain of the (2014) (0)
Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach (2011) (0)

This paper list is powered by the following services:

Other Resources About Martina Sester

en.wikipedia.org
www.uniklinikum-saarland.de

What Schools Are Affiliated With Martina Sester?

Martina Sester is affiliated with the following schools:

Saarland University
University of Warwick